Library

5-APDI

5-APDI (IAP) is a potent but weakly selective serotonin-releasing agent with IC50 values of 82 nM for serotonin, 1,848 nM for dopamine, and 849 nM for norepinephrine. Users report empathogenic warmth, mental stimulation, and occasionally mild visuals, but also pronounced body-load including hyperthermia, profuse sweating, bowel urgency, bruxism, and insomnia. Onset is slow; premature redosing has produced serotonin syndrome-like reactions. Cardiovascular stress and unpredictable individual response make conservative titration and external temperature control essential. Milligram-scale weighing and reagent testing are strongly advised.

Also known as: Iap, 2-api, Indanametamine, Indanylaminopropane, Indanylaminopropane, indanylamphetamine, 5-apdi, 5-iap, Indanylamphetamine, 5-IAP

Classification

  • Chemical: Aminoindane
  • Chemical: Amphetamine
  • Psychoactive: Entactogen
  • Psychoactive: Psychedelic
  • Psychoactive: Stimulant
  • Tag: Empathogen
  • Tag: Research-Chemical
  • Tag: Tentative

Effects

  • Stimulation
  • Teeth Grinding
  • Gastrointestinal Discomfort
  • Diarrhea
  • Excessive Perspiration
  • Pupil Dilation
  • Euphoria
  • Increased Sociability
  • Empathy Enhancement
  • Anxiety
  • Mood Lift
  • Excessive Talking
  • Music Enhancement
  • Visual Enhancement
  • Tracers
  • Increased Sexuality
  • Visual And Audiotory Hallucinations Itchiness
  • Increased Music Appreciation

Routes of Administration

Oral

Dosage

  • Threshold: 10 mg
  • Light: 15-25 mg
  • Common: 25-50 mg
  • Strong: 50-75 mg
  • Heavy: 75+ mg

Duration

  • Onset: 0.5-1.5 h
  • Peak: 2-5 h
  • Offset: 3-6 h
  • After Effects: 1-6 h
  • Total Duration: 8-14 h

Insufflated

Dosage

  • Threshold: 5 mg
  • Light: 5-10 mg
  • Common: 10-20 mg
  • Strong: 20-30 mg
  • Heavy: 30+ mg

Duration

  • Onset: 0.08-0.25 h
  • Peak: 2-4 h
  • Offset: 2-4 h
  • After Effects: 1-6 h
  • Total Duration: 6-12 h

Intravenous

Dosage

  • Threshold: 2 mg
  • Light: 3-5 mg
  • Common: 5-10 mg
  • Strong: 10-15 mg
  • Heavy: 15+ mg

Duration

  • Onset: 0.02-0.08 h
  • Peak: 2-4 h
  • Offset: 2-4 h
  • After Effects: 1-6 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

5-APDI - Ghid de substanțe DrugsPRO

5-APDI: 5-APDI (IAP) is a potent but weakly selective serotonin-releasing agent with IC50 values of 82 nM for serotonin, 1,848 nM for dopamine, and 849 nM for norepinephrine. Users report empathogenic warmth, mental stimulation, and occasionally mild visuals, but also pronounced body-load including

Related pages